"We're starting this because we believe it could work," Eli Lilly CEO David Ricks told CNBC in explaining the company's partnership with AbCellera Biologics.
from Business News https://ift.tt/38UEpRf
via IFTTT
Friday, March 13, 2020
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment